Global Muscle Relaxant Drugs Market Professional Survey Report 2019

Muscle spasticity is caused by damage to the spinal cord or brain. Nerves in the brain and spinal cord help relax the muscles during the idle state. Conditions that affect the brain or spinal cord such as multiple sclerosis, cerebral palsy, and stroke can interfere with normal muscle relaxation, leading to involuntary muscle spasms. This will impair the ability to walk, work, sleep, or just function normally. The muscles can also become excessively tense and develop overactive or overresponsive reflexes. Severe cases can lead to deep disability, including an inability to straighten out joints. Muscle relaxant drugs are primarily used in conjunction with general anesthetics to achieve muscle relaxation during surgical interventions.
Old age is associated with the loss of fibrous tissue, and reduced vascular and glandular network in the layers of skin. In the elderly population, the appearance and characteristics of the skin gets altered, leading to wrinkles, appearance of frown lines, dryness, pigmentary alteration, and sagging of the skin. Muscle relaxant-based procedures help in reducing skin aging, thus giving younger look to a person by revitalizing and tightening the skin.

The global Muscle Relaxant Drugs market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Muscle Relaxant Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Muscle Relaxant Drugs market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Muscle Relaxant Drugs in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Muscle Relaxant Drugs manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Pfizer
Allergan
Ipsen Group
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical
Merz Pharma
Mylan
Fresenius Kabi
Endo International
Par Sterile Products
Acorda Therapeutics
SteriMax Inc
Emcure Pharmaceuticals
Upsher-Smith Laboratories
Orient Pharma
Daewoong Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Skeletal Muscle Relaxant Drugs
Facial Muscle Relaxant Drugs

Segment by Application
Hospital Pharmacies
Retail Pharmacies
Others

Frequently Asked Questions